Search
very low-density lipoprotein receptor; VLDL receptor; VLDL-R (VLDLR)
Function:
- binds VLDL & transports it into cells by endocytosis
- receptor-ligand complexes cluster into clathrin-coated pits prior to endocytosis
- binding to Reelin induces Tyr phosphorylation of Dab1 & modulation of Tau phosphorylation (putative)
- binds to the extracellular matrix protein Reelin
- interacts with VLDLR
- interacts with SNX17 (putative)
- interacts with DAB1
- receptor for the minor-group human rhinoviruses (HRVs)
- binds protein VP1 through the 2nd & 3rd LDL-receptor class A domains
- VLDL receptor binds apolipoprotein E
Structure:
- contains 3 EGF-like domains
- contains 8 LDL-receptor class A domains
- contains 6 LDL-receptor class B repeats
Compartment:
- membrane
- clathrin-coated pit
Alternative splicing: named isoforms=2
Expression:
- abundant in heart & skeletal muscle
- also expressed in ovary & kidney
- tissue distribution of the VLDL receptor is very different from the LDL receptor
- mRNA for the VLDL receptor is abundant in cells with active fatty acid metabolism, including heart, muscle & adipose tissue
- very little is expressed in liver.
Pathology:
- deletions involving VLDLR may be the cause of VLDLR-associated cerebellar hypoplasia
Related
very low-density lipoprotein [VLDL] receptor gene
General
glycoprotein
lipoprotein receptor
Properties
SIZE: entity length = 873 aa
MW = 96 kD
COMPARTMENT: cellular membrane
MOTIF: signal sequence {1-27}
LDL-receptor class A {31-69}
MOTIF: cysteine residue {C33}
MODIFICATION: cysteine residue {C45}
cysteine residue {C40}
MODIFICATION: cysteine residue {C58}
cysteine residue {C45}
MODIFICATION: cysteine residue {C33}
cysteine residue {C52}
MODIFICATION: cysteine residue {C67}
cysteine residue {C58}
MODIFICATION: cysteine residue {C40}
cysteine residue {C67}
MODIFICATION: cysteine residue {C52}
LDL-receptor class A {70-110}
MOTIF: cysteine residue {C72}
MODIFICATION: cysteine residue {C84}
cysteine residue {C79}
MODIFICATION: cysteine residue {C97}
cysteine residue {C84}
MODIFICATION: cysteine residue {C72}
cysteine residue {C91}
MODIFICATION: cysteine residue {C108}
cysteine residue {C97}
MODIFICATION: cysteine residue {C79}
cysteine residue {C108}
MODIFICATION: cysteine residue {C91}
LDL-receptor class A {111-151}
MOTIF: cysteine residue {C113}
MODIFICATION: cysteine residue {C127}
cysteine residue {C120}
MODIFICATION: cysteine residue {C140}
cysteine residue {C127}
MODIFICATION: cysteine residue {C113}
cysteine residue {C134}
MODIFICATION: cysteine residue {C149}
cysteine residue {C140}
MODIFICATION: cysteine residue {C120}
cysteine residue {C149}
MODIFICATION: cysteine residue {C134}
N-glycosylation site {N151}
LDL-receptor class A {152-190}
MOTIF: cysteine residue {C154}
MODIFICATION: cysteine residue {C166}
cysteine residue {C161}
MODIFICATION: cysteine residue {C179}
cysteine residue {C166}
MODIFICATION: cysteine residue {C154}
cysteine residue {C173}
MODIFICATION: cysteine residue {C188}
cysteine residue {C179}
MODIFICATION: cysteine residue {C161}
cysteine residue {C188}
MODIFICATION: cysteine residue {C173}
LDL-receptor class A {191-231}
MOTIF: cysteine residue {C193}
MODIFICATION: cysteine residue {C205}
cysteine residue {C200}
MODIFICATION: cysteine residue {C218}
cysteine residue {C205}
MODIFICATION: cysteine residue {C193}
cysteine residue {C212}
MODIFICATION: cysteine residue {C229}
cysteine residue {C218}
MODIFICATION: cysteine residue {C200}
cysteine residue {C229}
MODIFICATION: cysteine residue {C212}
LDL-receptor class A {237-275}
MOTIF: cysteine residue {C239}
MODIFICATION: cysteine residue {C251}
cysteine residue {C246}
MODIFICATION: cysteine residue {C264}
cysteine residue {C251}
MODIFICATION: cysteine residue {C239}
cysteine residue {C258}
MODIFICATION: cysteine residue {C273}
cysteine residue {C264}
MODIFICATION: cysteine residue {C246}
cysteine residue {C273}
MODIFICATION: cysteine residue {C258}
LDL-receptor class A {276-314}
MOTIF: cysteine residue {C278}
MODIFICATION: cysteine residue {C290}
cysteine residue {C285}
MODIFICATION: cysteine residue {C303}
cysteine residue {C290}
MODIFICATION: cysteine residue {C278}
cysteine residue {C297}
MODIFICATION: cysteine residue {C312}
cysteine residue {C303}
MODIFICATION: cysteine residue {C285}
cysteine residue {C312}
MODIFICATION: cysteine residue {C297}
LDL-receptor class A {316-355}
MOTIF: cysteine residue {C318}
MODIFICATION: cysteine residue {C331}
cysteine residue {C326}
MODIFICATION: cysteine residue {C344}
cysteine residue {C331}
MODIFICATION: cysteine residue {C318}
cysteine residue {C338}
MODIFICATION: cysteine residue {C355}
cysteine residue {C344}
MODIFICATION: cysteine residue {C326}
cysteine residue {C355}
MODIFICATION: cysteine residue {C338}
EGF domain {356-395}
MOTIF: cysteine residue {C360}
MODIFICATION: cysteine residue {C371}
cysteine residue {C367}
MODIFICATION: cysteine residue {C380}
cysteine residue {C371}
MODIFICATION: cysteine residue {C360}
cysteine residue {C380}
MODIFICATION: cysteine residue {C367}
cysteine residue {C382}
MODIFICATION: cysteine residue {C394}
cysteine residue {C394}
MODIFICATION: cysteine residue {C382}
EGF domain {396-435}
MOTIF: cysteine residue {C400}
MODIFICATION: cysteine residue {C410}
cysteine residue {C406}
MODIFICATION: cysteine residue {C419}
cysteine residue {C410}
MODIFICATION: cysteine residue {C400}
cysteine residue {C419}
MODIFICATION: cysteine residue {C406}
cysteine residue {C421}
MODIFICATION: cysteine residue {C434}
cysteine residue {C434}
MODIFICATION: cysteine residue {C421}
LDL-receptor class B {439-480}
LDL-receptor class B {481-524}
LDL-receptor class B {525-567}
LDL-receptor class B {568-611}
LDL-receptor class B {612-654}
LDL-receptor class B {655-697}
EGF domain {702-750}
MOTIF: cysteine residue {C706}
MODIFICATION: cysteine residue {C719}
cysteine residue {C715}
MODIFICATION: cysteine residue {C734}
cysteine residue {C719}
MODIFICATION: cysteine residue {C706}
cysteine residue {C734}
MODIFICATION: cysteine residue {C715}
cysteine residue {C736}
MODIFICATION: cysteine residue {C749}
cysteine residue {C749}
MODIFICATION: cysteine residue {C736}
domain {751-790}
MOTIF: N-glycosylation site {N765}
N-glycosylation site {N781}
transmembrane domain {798-819}
Endocytosis signal {832-837}
MISC-INFO: LIGAND = APOLIPOPROTEIN_E
Database Correlations
OMIM correlations
UniProt P98155
PFAM correlations
Entrez Gene 7436
Kegg hsa:7436
References
- Sakai J et al
Structure, chromosome location, and expression of the human
very low density lipoprotein receptor gene.
J Biol Chem. 1994 Jan 21;269(3):2173-82.
PMID: 8294473
- UniProt :accession P98155
- SeattleSNPs
http://pga.gs.washington.edu/data/vldlr/